Cost for QD employees to rent an apartment in Chico, CA. $1,200/month. Please turn off your ad blocker in Quality Digest
Our landlords thank you.
greenlight.guru
Published: Tuesday, November 20, 2018 - 14:40 (Greenlight Guru: Indianapolis) -- Greenlight Guru, the only quality management software platform designed specifically for medical device companies, announces a new integration with Jira, creating an adaptive system for managing product development and post-market quality for devices with software elements. Medical device design controls have historically been a top observation cited by the U.S. Food and Drug Administration (FDA) during inspections, with many medical device companies struggling to demonstrate robust design controls via traditional spreadsheets or disconnected sets of documentation. With the growth of Software as a Medical Device (SaMD) applications, along with the proliferation of hardware-based devices now incorporating software or firmware elements, managing and maintaining design control traceability has become increasingly complex. “Modern medical devices contain hardware, software, and firmware levels, each of which is commonly owned and developed by cross-functional teams,” says Jon Speer, Greenlight Guru co-founder and vice president of quality assurance and regulatory affairs. “This integration allows product managers to track and maintain compliance mandated by regulatory bodies while enabling software development in one of the most popular and adaptable management environments in the industry.” The new integration allows medical device companies to reduce the risk of noncompliance by ensuring the appropriate Jira artifacts are captured in their quality management system. Software development teams have the freedom to leverage the agile functionality of Jira for tracking implementation work and issues related to software components, while simultaneously ensuring traceability to their design control and risk management system of record within Greenlight Guru. “The agile development approach has helped bring about world-class technology like Gmail, Spotify, and Salesforce,” says Greenlight Guru co-founder and CEO David DeRam. “Greenlight Guru and Jira are the industry leaders in their respective fields, and this new partnership will help usher in the next generation of quality-focused medical devices to market.” This announcement follows Greenlight Guru’s Advanced Document Management software release and a recent partnership with the FDA that has provided meaningful insight into the FDA’s Case for Quality initiative. For more information about Greenlight Guru’s new Jira integration, visit www.greenlight.guru/design-control-software. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, Greenlight Guru is the only quality management software designed specifically for the medical device industry.Greenlight Guru Announces New Integration With Jira Software
Creates adaptive system for managing product development and post-market quality for devices with software elements
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
greenlight.guru
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.